218728 Sigma-AldrichCaspase-9 Inhibitor III - CAS 403848-57-7 - Calbiochem
The Caspase-9 Inhibitor III, also referenced under CAS 403848-57-7, controls the biological activity of Caspase-9. This small molecule/inhibitor is primarily used for Cancer applications.
More>> The Caspase-9 Inhibitor III, also referenced under CAS 403848-57-7, controls the biological activity of Caspase-9. This small molecule/inhibitor is primarily used for Cancer applications. Less<<Synonyms: Ac-LEHD-CMK
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
CAS # | Empirical Formula |
---|---|
403848-57-7 | C₂₄H₃₅ClN₆O₉ |
Products
Catalog Number | Packaging | Qty/Pack | |
---|---|---|---|
218728-1MG | Plastic ampoule | 1 mg |
References | |
---|---|
References | Mocanu, M.M., et al. 2000. Br. J. Pharmacol. 130, 197. |
Product Information | |
---|---|
CAS number | 403848-57-7 |
ATP Competitive | N |
Form | White solid |
Formulation | Supplied as a trifluoroacetate salt. |
Hill Formula | C₂₄H₃₅ClN₆O₉ |
Chemical formula | C₂₄H₃₅ClN₆O₉ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | caspase-9 |
Primary Target IC<sub>50</sub> | 70 nM against caspase-9 |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Peptide Sequence | Ac-Leu-Glu-His-Asp-CMK |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
218728-1MG | 07790788048594 |
Documentation
Caspase-9 Inhibitor III - CAS 403848-57-7 - Calbiochem SDS
Title |
---|
Caspase-9 Inhibitor III - CAS 403848-57-7 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
218728 |
References
Reference overview |
---|
Mocanu, M.M., et al. 2000. Br. J. Pharmacol. 130, 197. |